Paper36250331
Mitochondrial mitophagy protection combining rivaroxaban and aspirin in high glucose-exposed human coronary artery endothelial cell. An in vitro study.
Zekri-Nechar K and 7 others. Diab Vasc Dis Res, 2022. Cited by 14 papers, by iCite.
Cite this record
ConductScience Library. Mitochondrial mitophagy protection combining rivaroxaban and aspirin in high glucose-exposed human coronary artery endothelial cell. An in vitro study. Papers, record 36250331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36250331
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Mitochondrial mitophagy protection combining rivaroxaban and aspirin in high glucose-exposed human coronary artery endothelial cell. An in vitro study.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Aspirin | Major topic |
| Rivaroxaban | Major topic |
| Coronary Vessels | |
| Endothelial Cells | |
| Endothelium | |
| Factor Xa | |
| Glucose | |
| Humans | |
| Mitochondria | |
| Mitophagy | |
| Reactive Oxygen Species | |
| Thromboplastin | |
| Ubiquitin-Protein Ligases |
Source PubMed
References12
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27221050 | Inducing mitophagy in diabetic platelets protects against severe oxidative stress. | EMBO Mol Med | 2016 | https://conductscience.org/library/papers/27221050 | PubMed |
| 2 | 25969707 | Phosphatase and tensin homolog-induced putative kinase 1 and Parkin in diabetic heart: Role of mitophagy. | J Diabetes Investig | 2015 | https://conductscience.org/library/papers/25969707 | PubMed |
| 3 | 18687901 | Loss of PINK1 causes mitochondrial functional defects and increased sensitivity to oxidative stress. | Proc Natl Acad Sci U S A | 2008 | https://conductscience.org/library/papers/18687901 | PubMed |
| 4 | 33111589 | Pro-apoptotic properties and mitochondrial functionality in platelet-like-particles generated from low Aspirin-incubated Meg-01 cells. | Platelets | 2021 | https://conductscience.org/library/papers/33111589 | PubMed |
| 5 | 17475204 | Selective degradation of mitochondria by mitophagy. | Arch Biochem Biophys | 2007 | https://conductscience.org/library/papers/17475204 | PubMed |
| 6 | 18388497 | Persistent factor VIII-dependent factor X activation on endothelial cells is independent of von Willebrand factor. | Blood Coagul Fibrinolysis | 2008 | https://conductscience.org/library/papers/18388497 | PubMed |
| 7 | 22326220 | Mitochondrial fission triggered by hyperglycemia is mediated by ROCK1 activation in podocytes and endothelial cells. | Cell Metab | 2012 | https://conductscience.org/library/papers/22326220 | PubMed |
| 8 | 28844192 | Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease. | N Engl J Med | 2017 | https://conductscience.org/library/papers/28844192 | PubMed |
| 9 | 32029851 | Production and control of coagulation proteins for factor X activation in human endothelial cells and fibroblasts. | Sci Rep | 2020 | https://conductscience.org/library/papers/32029851 | PubMed |
| 10 | 28736426 | Modulation of Mitochondrial Membrane Potential and ROS Generation by Nicotinamide in a Manner Independent of SIRT1 and Mitophagy. | Mol Cells | 2017 | https://conductscience.org/library/papers/28736426 | PubMed |
| 11 | 32173474 | Factor Xa Inhibition by Rivaroxaban Modified Mitochondrial-Associated Proteins in Human Abdominal Aortic Aneurysms. | Ann Vasc Surg | 2020 | https://conductscience.org/library/papers/32173474 | PubMed |
| 12 | 8972019 | Acetylsalicylic acid and sodium salicylate inhibit LPS-induced NF-kappa B/c-Rel nuclear translocation, and synthesis of tissue factor (TF) and tumor necrosis factor alfa (TNF-alpha) in human monocytes. | Thromb Haemost | 1996 | https://conductscience.org/library/papers/8972019 | PubMed |
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 14 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41524040 | Metabolic Remodeling and Mitochondrial Stress in Atrial Fibrillation: Mechanisms and Translational Targets. | Rev Cardiovasc Med | 2025 | https://conductscience.org/library/papers/41524040 | PubMed |
| 40786081 | Bibliometric analysis of research hotspots and emerging trends in mitophagy and atherosclerosis (2004-2024). | Front Med (Lausanne) | 2025 | https://conductscience.org/library/papers/40786081 | PubMed |
| 40216698 | The Impact of Liraglutide, a GLP-1 Receptor Agonist, on High Glucose-Induced Inflammation, Apoptosis, Oxidative Stress, and NLRP3 Signaling. | Cell Biochem Biophys | 2025 | https://conductscience.org/library/papers/40216698 | PubMed |
| 39861173 | Dysregulation of Mitochondrial Homeostasis in Cardiovascular Diseases. | Pharmaceuticals (Basel) | 2025 | https://conductscience.org/library/papers/39861173 | PubMed |
| 39767627 | Mitochondrial Dysfunction in Atrial Fibrillation: The Need for a Strong Pharmacological Approach. | Biomedicines | 2024 | https://conductscience.org/library/papers/39767627 | PubMed |
| 39765678 | Consequences of Early Maternal Deprivation on Neuroinflammation and Mitochondrial Dynamics in the Central Nervous System of Male and Female Rats. | Biology (Basel) | 2024 | https://conductscience.org/library/papers/39765678 | PubMed |
| 38486493 | Role of PTEN-Induced Protein Kinase 1 as a Mitochondrial Dysfunction Regulator in Cardiovascular Disease Pathogenesis. | Vasc Specialist Int | 2024 | https://conductscience.org/library/papers/38486493 | PubMed |
| 37841935 | Distinct pleiotropic effects of direct oral anticoagulants on cultured endothelial cells: a comprehensive review. | Front Pharmacol | 2023 | https://conductscience.org/library/papers/37841935 | PubMed |
| 37261351 | Mitophagy in atherosclerosis: from mechanism to therapy. | Front Immunol | 2023 | https://conductscience.org/library/papers/37261351 | PubMed |
| 36605901 | Mitochondrial dysfunction in vascular endothelial cells and its role in atherosclerosis. | Front Physiol | 2022 | https://conductscience.org/library/papers/36605901 | PubMed |
Genes7
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| F10 | 2159 | PubTator's text mining | https://conductscience.org/library/genes/2159 | NCBI Gene |
| F2 | 2147 | PubTator's text mining | https://conductscience.org/library/genes/2147 | NCBI Gene |
| F3 | 2152 | PubTator's text mining | https://conductscience.org/library/genes/2152 | NCBI Gene |
| F7 | 2155 | PubTator's text mining | https://conductscience.org/library/genes/2155 | NCBI Gene |
| F8 | 2157 | PubTator's text mining | https://conductscience.org/library/genes/2157 | NCBI Gene |
| PINK1 | 65018 | PubTator's text mining | https://conductscience.org/library/genes/65018 | NCBI Gene |
| PRKN | 5071 | PubTator's text mining | https://conductscience.org/library/genes/5071 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36250331
GET https://conductscience.org/api/papers/v1/36250331/authors